It is noteworthy that our findings are in striking contrast to the previously reported role of Th17 and IL-17 in glioma promotion, where a direct correlation between two-year progression-free survival and low incidence of IL-17 producing cells was reported [55]. This evidence concerns the gene IL17A and central nervous system cancer.